Symbolbild · KI-generiert
HealWELL AI Inc. Class A Subordinate Voting Shares
Stock factsheet
Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.
Company profile
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. Using its own proprietary technology, the Company is developing and commercializing advanced clinical decision support systems that can help healthcare providers detect rare and chronic diseases, improve efficiency of their practice and ultimately help improve patient health outcomes. HEALWELL is executing a strategy centered around developing and acquiring technology and clinical sciences capabilities that complement the Company's road map. HEALWELL is publicly traded on the Toronto Stock Exchange under the symbol 'AIDX' and on the OTC Exchange under the symbol 'HWAIF'.
Company description as published by the issuer via TMX Money.
Share price
Price data from TradingView, possibly delayed. Not investment advice.
Comparable companies
Companies in the Biotech & Pharma sector of a similar size.
| Company | Ticker | Exchange | Market cap |
|---|---|---|---|
| HealWELL AI Inc. Class A Subordinate Voting Shares | AIDX | TSX | 141 Mio. USD |
| Cardiol Therapeutics Inc. | CRDL | TSX | 145 Mio. USD |
| Organigram Global Inc. | OGI | TSX | 132 Mio. USD |
| Cannara Biotech Inc. | LOVE | TSX | 131 Mio. USD |
| Hydreight Technologies Inc. | NURS | TSXV | 153 Mio. USD |
| TerrAscend Corp. | TSND | TSX | 154 Mio. USD |
| Custom Health Holdings Inc. | CHLT | TSX | 122 Mio. USD |
Investor Relations
We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.
Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.